Jay L. Katz, MD, FACS , Chief Medical Officer
Dr. Katz has served as our Chief Medical Officer since February 2017. He is currently employed by our company on a part-time basis while maintaining his Philadelphia-based ophthalmology practice and involvement in clinical research and medical education. Dr. Katz completed his glaucoma fellowship at Wills Eye Hospital in Philadelphia in 1985 and has been affiliated with the hospital since that time, currently serving as its director of glaucoma service. Since 1997, he has also served as a professor of ophthalmology at Jefferson Medical College at Thomas Jefferson University. He is a former member of the board and past treasurer of the American Glaucoma Society, a diplomate and associate examiner for the American Board of Ophthalmology and a fellow, member-at-large and past president of the Philadelphia Metro chapter of the American College of Surgeons. He has published more than 200 articles in ophthalmic journals and served as an investigator in landmark glaucoma trials, including the Advanced Glaucoma Intervention Study (AGIS) and Collaborative Initial Glaucoma Treatment Study (CIGTS). Dr. Katz completed his residency at Yale University and internship at the University of Virginia after earning his M.D. from Yale University Medical School. He holds a B.A. (summa cum laude) from Case Western Reserve University.